Adverse Effects of Pain Medication Used in Sport Medicine
DOI:
https://doi.org/10.12775/QS.2026.50.68180Keywords
Analgesia, adverse effects, sport medicine, acute pain, chest pain, pharmacotherapyAbstract
Background: Acute and chronic pain is a very common problem amongst people involved in sports, whether professionally or recreationally. Most of them require the use of medication in order to alleviate the pain. Extensive use of pain medication is burdened with an increased risk of adverse effects.
Aim: The aim of this narrative review is to summarise the adverse effects of the most popular pain management medication currently in use in sport medicine.
Material and methods: A comprehensive literature review was conducted via the advanced research tool in PubMed in order to find eligible and relevant articles regarding pain medication and their adverse effects.
Results: Extensive intake of NSAIDs in high doses increases the risk of gastrointestinal bleeding. The greatest concern regarding the use of paracetamol is its hepatotoxicity. Antidepressants are characterised by a wide variety of adverse effects, such as hypertension, dry mouth, constipation, and an increased risk of falls. The most common adverse effects of gabapentinoids are somnolence, fatigue, and dizziness.
Conclusions: Most injuries experienced by athletes can be managed with NSAIDs, acetaminophen, and weak oral opioids prescribed for a short period of time, whereas chronic pain treatment should start with TCAs, SNRIs, or gabapentinoids. Prolonged intake of pain medication increases the risk of the occurrence of serious adverse effects. Physicians ought to monitor their patients and act accordingly should any adverse effects occur.
References
1. Raja SN, Carr DB, Cohen M, Finnerup NB et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain 2020;161(9):1976-1982. https://doi.org/10.1097/j.pain.0000000000001939
2. https://icd.who.int/browse/2025-01/mms/en#1581976053 – accessed 3.01.2026
3. https://icd.who.int/browse/2025-01/mms/en#1404135736 – accessed 3.01.2026
4. https://www.iasp-pain.org/resources/terminology/ - accessed 3.01.2026
5. Owoeye OBA, Neme JR, Buchanan P, Esposito F, Preitbach AP. Absence of Injury Is Not Absence of Pain: Prevalence of Preseason Musculoskeletal Pain and Associated Factors in Collegiate Soccer and Basketball Student Athletes. Int J Environ Res Public Health. 2022;19(15):9128. https://doi.org/10.3390/ijerph19159128
6. Amarttayakong L, Ruengyangmee S, Nualkim W, Meelam P et al. An analysis of pain intensity, injury incidence, and their associations with socio-demographic factors in high school athletes: A cross-sectional study during the COVID-19 pandemic. PLoS One 2023;18(9):e0290587. https://doi.org/10.1371/journal.pone.0290587
7. Fett D, Trompeter K, Platen P. Back pain in elite sports: A cross-sectional study on 1114 athletes. PLoS One 2017;12:e0180130. https://doi.org/10.1371/journal.pone.0180130
8. Palmer D, Cooper D, Whittaker JL, Emery Carolyn et al. Prevalence of and factors associated with osteoarthritis and pain in retired Olympians compared with the general population: part 2 - the spine and upper limb. Br J Sports Med. 2022;bjsports-2021-104978. https://doi.org/10.1136/bjsports-2021-104978
9. Christopher S, Tadlock BA, Veroneau BJ, Harnish C et al. Epidemiological profile of pain and non-steroid anti-inflammatory drug use in collegiate athletes in the United States. BMC Musculoskelet Disord. 2020;21:561. https://doi.org/10.1186/s12891-020-03581-y
10. Jonasson P, Halldin K, Karlsson J, Thoreson O et al. Prevalence of joint-related pain in the extremities and spine in five groups of top athletes. Knee Surg Sports Traumatol Arthrosc. 2011; 19:1540-6. https://doi.org/10.1007/s00167-011-1539-4
11. Wilson F, Ardern CL, Hartvigsen J, Dane K et al. Prevalence and risk factors for back pain in sports: a systematic review with meta-analysis. Br J Sports Med. 2020; Oct 19:bjsports-2020-102537. https://doi.org/10.1136/bjsports-2020-102537
12. Farì G, Fischetti F, Zonno A, Marra F et al. Musculoskeletal Pain in Gymnasts: A Retrospective Analysis on a Cohort of Professional Athletes. Int J Environ Res Public Health 2021; 18(10):5460. https://doi.org/10.3390/ijerph18105460
13. Tscholl PM, Vaso M, Weber A, Dvorak J. High prevalence of medication use in professional football tournaments including the World Cups between 2002 and 2014: a narrative review with a focus on NSAIDs. Br J Sports Med. 2015;49(9):580-2. https://doi.org/10.1136/bjsports-2015-094784
14. Cashman JN. The Mechanisms of Action of NSAIDs in Analgesia. Drugs 1996;52(5):13-23. https://doi.org/10.2165/00003495-199600525-00004
15. Moore RA, Wiffen PJ, Derry S, MAguire T, Roy YM, Tyrrell L. Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;11:CD010794. https://doi.org/10.1002/14651858.cd010794.pub2
16. Busse JW, Sadeghirad B, Oparin Y, Chen E et al. Management of Acute Pain From Non-Low Back, Musculoskeletal Injuries: A Systematic Review and Network Meta-analysis of Randomized Trials. Ann Intern Med. 2020;173:730-738. https://doi.org/10.7326/m19-3601
17. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340(24):1888-99. https://doi.org/10.1056/nejm199906173402407
18. Scheiman JM. Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseases. Drugs 2006;66:15-21. https://doi.org/10.2165/00003495-200666001-00004
19. Gunnar H. Gislason, MD; Søren Jacobsen, MD, DMSc; Jeppe N. Rasmussen, MD; Søren Rasmussen, MSc, PhD. Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction. Circulation 2006;113(25):2906-13. https://doi.org/10.1161/circulationaha.106.616219
20. Lilja M, Mandic M, Apro W, et al. High doses of antiinflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults. Acta Physiol (Oxf). 2018;222(2):1-16. https://doi.org/10.1111/apha.12948
21. Derry S, Conaghan P, Da Silva JAP, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. 2016(4):CD007400. https://doi.org/10.1002/14651858.CD007400.pub3
22. Rother M, Conaghan PG. A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. J. Rheumatol. 2013;40(10):1742-8. https://doi.org/10.3899/jrheum.130192
23. Ohashi N, Kohno T. Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action. Fron Pharmacol. 2020;11:580289. https://doi.org/10.3389/fphar.2020.580289
24. Ridderikhof ML, Saanen J, Goddijn H, Van Dieren S et al. Paracetamol versus other analgesia in adult patients with minor musculoskeletal injuries: a systematic review. Emerg Med J 2019;36(8):493-500. https://doi.org/10.1136/emermed-2019-208439
25. Bouchiba M, Turki M, Zarzissi S, Zghal F et al. Acute acetaminophen ingestion improves the recovery of neuromuscular fatigue following simulated soccer match-play. J Sci Med Sport 2025;28(3)189-197. https://doi.org/10.1016/j.jsams.2024.11.002
26. Finnerup NB. Nonnarcotic Methods of Pain Management. N Engl J Med 2019;380:2440-2448. https://doi.org/10.1056/nejmra1807061
27. Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol. 2009;43(4):342-9. https://doi.org/10.1097/mcg.0b013e31818a3854
28. Yaksh TL. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol Scand. 1997;41:94-111. https://doi.org/10.1111/j.1399-6576.1997.tb04623.x
29. Jones CMP, Lin CWC, Jamshidi M, Shaheed CA et al. Effectiveness of Opioid Analgesic Medicines Prescribed in or at Discharge From Emergency Departments for Musculoskeletal Pain : A Systematic Review and Meta-analysis. Ann Intern Med 2022;157(11)1572-1581. https://doi.org/10.7326/m22-2162
30. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112 (3): 372-80. https://doi.org/10.1016/j.pain.2004.09.019
31. Tassinari D, Sartori S, Tamburini E, Scarpi E et al. Transdermal fentanyl as a front-line approach to moderate-severe pain: a meta-analysis of randomized clinical trials. J Palliat Care 2009; 25 (3): 172-80.
32. Cherny N, Ripamonti C, Pereira J, Davis C et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001; 19 (9): 2542-54. https://doi.org/10.1200/jco.2001.19.9.2542
33. McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003; 4 (5): 231-56. https://doi.org/10.1016/s1526-5900(03)00556-x
34. Baldo BA, Rose MA. Mechanisms of opioid-induced respiratory depression. Arch Toxicol 2022;96(8):2247-60. https://doi.org/10.1007/s00204-022-03300-7
35. Cherny NI. Opioid analgesics: comparative features and prescribing guidelines. Drugs 1996;51(5):730. https://doi.org/10.2165/00003495-199651050-00002
36. Thomas KH, Dalili MN, Cheng HY, Dawson S et al. Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain: A systematic review and meta-analysis. Addiction 2024;119(11):1904-1922. https://doi.org/10.1111/add.16616
37. Raith K, Hochhaus G. Drugs used in the treatment of opioid tolerance and physical dependence: a review. Int J Clin Pharmacol Ther 2004; 42 (4): 191-203. https://doi.org/10.5414/cpp42191
38. Noble M, Treadwell JR, Tregear SJ, Coates VH. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010;(1):CD005505. https://doi.org/10.1002/14651858.cd006605.pub2
39. Warrington SJ. Clinical Implications of the Pharmacology of Serotonin Reuptake Inhibitors. Int. Clin. Psychopharmacol. 1992;7(2):13-19. https://doi.org/10.1097/00004850-199210002-00004
40. Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet 2011;377:2226-235. https://doi.org/10.1016/s0140-6736(11)60402-9
41. Finnerup NB, Attal N, Haroutounian S, McNicol E et al. Pharmacotherapy for neuropathic pain in adults: systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173. https://doi.org/10.1016/s1474-4422(14)70251-0
42. Lambert O, Bourin M. SNRIs: mechanism of action and clinical features. Expert Rev. Neurotherapeutics 2002;2(6):849-858. https://doi.org/10.1586/14737175.2.6.849
43. Montgomery S. Tolerability of serotonin norepinephrine reuptake inhibitor antidepressants. CSN Spectr 2008;13:27-33. https://doi.org/10.1017/s1092852900028297
44. Goodnick PJ, Goldstein BJ. Selective serotonin reuptake inhibitors in affective disorders – I. Basic pharmacology. J. Psychopharmacol. 1998;12:S5-20. https://doi.org/10.1177/0269881198012003021
45. Lee YC, Chen PP. A review of SSRIs and SNRIs in neuropathic pain. Expert Opin. Pharmacother. 2010;11(17):2813-2825. https://doi.org/10.1517/14656566.2010.507192
46. Pillinger T, Arumuham A, McCutcheon RA, D’Ambrosio E. The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis. Lancet 2025:406;2063–77. https://doi.org/10.1016/s0140-6736(25)01293-0
47. Taylor CP, Harris EW. Analgesia with Gabapentin and Pregabalin May Involve N-Methyl-d-Asparatate Receptors, Neurexins, and Thrombospondins. J Pharmacol Exp Ther. 2020;374(1):161-174. https://doi.org/10.1124/jpet.120.266056
48. Wiffen PJ, Derry S, Bell RF, Rice ASC, Tölle TR, Phillips T, Moore RA. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017 Jun 9;6(6):CD007938 https://doi.org/10.1002/14651858.cd007938.pub4
49. Zaccara G, Gangemi P, Perucca P, Specchio L. The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials. Epilepsia 2011;52(4):826-836. https://doi.org/10.1111/j.1528-1167.2010.02966.x
50. Evoy KR, Morrison MD, Saklad SR. Abuse and Misuse of Pregabalin and Gabapentin. Drugs 2017;77:403-426. https://doi.org/10.1007/s40265-017-0700-x
51. Herring SA, Kibler WB, Putukian M, Tauben D et al. Select Issues in Pain Management for the Youth and Adolescent Athlete. Medicine & Science in Sports & Exercise 2020;52(9):2037-46. https://doi.org/10.1249/mss.0000000000002333
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Mateusz Kubicki, Patryk Hebda, Roman Cemaga, Bartłomiej Błaszkowski, Adam Wolski, Maria Król, Paweł Pustuła, Ewa Szplit, Mieszko Czapliński, Wiktoria Michnowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 13
Number of citations: 0
